{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:15:53Z","timestamp":1771049753864,"version":"3.50.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"IUCPQ-UL"},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec-Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Risk stratification for sudden cardiac death in patients with Brugada syndrome remains a major challenge. Contemporary risk prediction models have only modest predictive value. The aim of this study was to assess the role of micro-RNAs from peripheral blood as candidate biomarkers in Brugada syndrome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>In this prospective study, Brugada patients and unaffected control individuals were enrolled for analysis of leucocyte-derived microRNAs (miRNAs) levels. Expression levels of 798 different circulating miRNAs were analysed on the NanoString\u00ae nCounter platform. All results were cross-validated by using a quantitative polymerase chain reaction. Micro-RNA expression levels of Brugada patients were compared with clinical data. A total of 21 definite Brugada patients (38% with a history of ventricular arrhythmia or cardiac arrest) and 30 unaffected control individuals were included in the study. Micro-RNA analysis showed a distinct expression profile in Brugada patients with 42 differentially expressed markers (38 up-regulated, 4 down-regulated miRNAs). The symptom status of Brugada patients was associated with a distinct miRNA signature. Micro-RNAs 145-5p and 585-3p were significantly up-regulated in symptomatic Brugada patients (P = 0.04). Incorporating miRNAs 145-5p and 585-3p into a multivariable model demonstrated significantly increased symptom prediction (area under the curve = 0.96; 95% confidence interval: 0.88\u20131.00).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Brugada patients display a distinct miRNA expression profile compared with unaffected control individuals. There is also evidence that certain miRNAs (miR-145-5p and miR-585-3p) are associated with the symptom status of Brugada patients. The results suggest the principal utility of leucocyte-derived miRNAs as prognostic biomarkers for Brugada syndrome.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euad145","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T11:53:43Z","timestamp":1686743623000},"source":"Crossref","is-referenced-by-count":7,"title":["Leucocyte-derived micro-RNAs as candidate biomarkers in Brugada syndrome"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4112-0028","authenticated-orcid":false,"given":"Christian","family":"Steinberg","sequence":"first","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5351-596X","authenticated-orcid":false,"given":"Nathalie","family":"Gaudreault","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0026-6581","authenticated-orcid":false,"given":"Andreas I","family":"Papadakis","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Montreal Jewish Hospital, McGill University , Montreal , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4202-4951","authenticated-orcid":false,"given":"Cyndi","family":"Henry","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9861-9351","authenticated-orcid":false,"given":"Jean","family":"Champagne","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Philippon","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1115-8108","authenticated-orcid":false,"given":"Gilles","family":"O\u2019Hara","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Blier","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Plourde","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Nault","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4299-9921","authenticated-orcid":false,"given":"Karine","family":"Roy","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1114-0661","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Sarrazin","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-1420","authenticated-orcid":false,"given":"Alan","family":"Spatz","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Montreal Jewish Hospital, McGill University , Montreal , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3067-3711","authenticated-orcid":false,"given":"Yohan","family":"Boss\u00e9","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et pneumologie de Qu\u00e9bec, Universit\u00e9 Laval , 2725, Chemin Ste-Foy, Quebec City , Canada G1V 4G5"},{"name":"Department of Molecular Medicine, Laval University , Quebec City , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"2023061411470614100_euad145-B1","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.hrthm.2015.04.014","article-title":"J-wave syndromes: Brugada and early repolarization syndromes","volume":"12","author":"Antzelevitch","year":"2015","journal-title":"Heart Rhythm"},{"key":"2023061411470614100_euad145-B2","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/j.hrthm.2016.05.024","article-title":"J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge","volume":"13","author":"Antzelevitch","year":"2016","journal-title":"Heart Rhythm"},{"key":"2023061411470614100_euad145-B3","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","article-title":"Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report","volume":"20","author":"Brugada","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"2023061411470614100_euad145-B4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.hrthm.2018.01.014","article-title":"Profile of patients with Brugada syndrome presenting with their first documented arrhythmic event: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS)","volume":"15","author":"Milman","year":"2018","journal-title":"Heart Rhythm"},{"key":"2023061411470614100_euad145-B5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.hrthm.2015.08.038","article-title":"Risk stratification in Brugada syndrome: clinical characteristics, electrocardiographic parameters, and auxiliary testing","volume":"13","author":"Adler","year":"2016","journal-title":"Heart Rhythm"},{"key":"2023061411470614100_euad145-B6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/HCO.0000000000000238","article-title":"Brugada syndrome: diagnosis, risk stratification, and management","volume":"31","author":"Adler","year":"2016","journal-title":"Curr Opin Cardiol"},{"key":"2023061411470614100_euad145-B7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1253\/circj.CJ-14-1059","article-title":"Risk stratification in patients with Brugada syndrome without previous cardiac arrest - prognostic value of combined risk factors","volume":"79","author":"Okamura","year":"2015","journal-title":"Circ J"},{"key":"2023061411470614100_euad145-B8","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehx119","article-title":"A score model to predict risk of events in patients with Brugada syndrome","volume":"38","author":"Sieira","year":"2017","journal-title":"Eur Heart J"},{"key":"2023061411470614100_euad145-B9","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/eurheartj\/ehx165","article-title":"Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives","volume":"39","author":"Poller","year":"2018","journal-title":"Eur Heart J"},{"key":"2023061411470614100_euad145-B10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2174\/1389201018666170623125842","article-title":"Biomarkers in cardiomyopathies and prediction of sudden cardiac death","volume":"18","author":"Kruska","year":"2017","journal-title":"Curr Pharm Biotechnol"},{"key":"2023061411470614100_euad145-B11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1515\/cclm-2016-0576","article-title":"MicroRNAs in cardiovascular disease - clinical application","volume":"55","author":"Schulte","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"2023061411470614100_euad145-B12","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2150763","article-title":"MicroRNAs in coronary heart disease: ready to enter the clinical arena?","volume":"2016","author":"Cavarretta","year":"2016","journal-title":"Biomed Res Int"},{"key":"2023061411470614100_euad145-B13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","article-title":"MicroRNA regulation of atherosclerosis","volume":"118","author":"Feinberg","year":"2016","journal-title":"Circ Res"},{"key":"2023061411470614100_euad145-B14","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.109.889048","article-title":"MicroRNAs add a new dimension to cardiovascular disease","volume":"121","author":"Small","year":"2010","journal-title":"Circulation"},{"key":"2023061411470614100_euad145-B15","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"2023061411470614100_euad145-B16","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/europace\/euac030","article-title":"European Heart Rhythm Association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases","volume":"24","author":"Wilde","year":"2022","journal-title":"Europace"},{"key":"2023061411470614100_euad145-B17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2217\/bmm-2016-0195","article-title":"Can nanotechnology improve cancer diagnosis through miRNA detection?","volume":"11","author":"Fiammengo","year":"2017","journal-title":"Biomark Med"},{"key":"2023061411470614100_euad145-B18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4939-9904-0_10","article-title":"NanoString nCounter technology: high-throughput RNA validation","volume":"2079","author":"Goytain","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2023061411470614100_euad145-B19","doi-asserted-by":"crossref","first-page":"D190","DOI":"10.1093\/nar\/gkv1254","article-title":"DIANA-miRGen v3.0: accurate characterization of microRNA promoters and their regulators","volume":"44","author":"Georgakilas","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2023061411470614100_euad145-B20","doi-asserted-by":"crossref","first-page":"D153","DOI":"10.1093\/nar\/gku1215","article-title":"DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions","volume":"43","author":"Vlachos","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2023061411470614100_euad145-B21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"key":"2023061411470614100_euad145-B22","doi-asserted-by":"crossref","first-page":"D239","DOI":"10.1093\/nar\/gkx1141","article-title":"DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions","volume":"46","author":"Karagkouni","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2023061411470614100_euad145-B23","doi-asserted-by":"crossref","first-page":"D239","DOI":"10.1093\/nar\/gkv1258","article-title":"miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database","volume":"44","author":"Chou","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2023061411470614100_euad145-B24","doi-asserted-by":"crossref","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","article-title":"miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions","volume":"46","author":"Chou","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2023061411470614100_euad145-B25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12859-019-3105-x","article-title":"MIENTURNET: an interactive web tool for microRNA-target enrichment and network-based analysis","volume":"20","author":"Licursi","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"2023061411470614100_euad145-B26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191629","article-title":"RLE plots: visualizing unwanted variation in high dimensional data","volume":"13","author":"Gandolfo","year":"2018","journal-title":"PLoS One"},{"key":"2023061411470614100_euad145-B27","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1093\/nar\/gkz433","article-title":"A new normalization for NanoString nCounter gene expression data","volume":"47","author":"Molania","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2023061411470614100_euad145-B28","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2023061411470614100_euad145-B29","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/bioinformatics\/btm412","article-title":"A comparison of background correction methods for two-colour microarrays","volume":"23","author":"Ritchie","year":"2007","journal-title":"Bioinformatics"},{"key":"2023061411470614100_euad145-B30","first-page":"8402","article-title":"Long non-coding RNA expression profile in atrial fibrillation","volume":"8","author":"Ruan","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"2023061411470614100_euad145-B31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jacep.2019.08.011","article-title":"Circulating miRNAs and risk of sudden death in patients with coronary heart disease","volume":"6","author":"Silverman","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"2023061411470614100_euad145-B32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","article-title":"An overview of microRNAs","volume":"87","author":"Hammond","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"2023061411470614100_euad145-B33","article-title":"Integration of \u201comics\u201d strategies for biomarkers discovery and for the elucidation of molecular mechanisms underlying Brugada syndrome","volume":"12","author":"Scumaci","year":"2018","journal-title":"Proteomics Clin Appl"},{"key":"2023061411470614100_euad145-B34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261390","article-title":"Plasma microRNAs as noninvasive diagnostic biomarkers in patients with Brugada syndrome","volume":"17","author":"Ikeuchi","year":"2022","journal-title":"PLoS One"},{"key":"2023061411470614100_euad145-B35","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.hrthm.2019.07.003","article-title":"Ethnic differences in patients with Brugada syndrome and arrhythmic events: new insights from Survey on Arrhythmic Events in Brugada Syndrome","volume":"16","author":"Milman","year":"2019","journal-title":"Heart Rhythm"},{"key":"2023061411470614100_euad145-B36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jacep.2020.08.032","article-title":"A primary prevention clinical risk score model for patients with Brugada syndrome (BRUGADA-RISK)","volume":"7","author":"Honarbakhsh","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2023061411470614100_euad145-B37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bj.2019.03.003","article-title":"Role of SCN5A coding and non-coding sequences in Brugada syndrome onset: what\u2019s behind the scenes?","volume":"42","author":"Daimi","year":"2019","journal-title":"Biomed J"},{"key":"2023061411470614100_euad145-B38","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.hrthm.2015.02.018","article-title":"Regulation of SCN5A by microRNAs: miR-219 modulates SCN5A transcript expression and the effects of flecainide intoxication in mice","volume":"12","author":"Daimi","year":"2015","journal-title":"Heart Rhythm"},{"key":"2023061411470614100_euad145-B39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCRESAHA.114.302810","article-title":"The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy","volume":"114","author":"Chen","year":"2014","journal-title":"Circ Res"},{"key":"2023061411470614100_euad145-B40","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.7150\/ijbs.28103","article-title":"Cardiac fibrosis: new insights into the pathogenesis","volume":"14","author":"Ma","year":"2018","journal-title":"Int J Biol Sci"},{"key":"2023061411470614100_euad145-B41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/abbs\/gmy007","article-title":"The TGFbeta superfamily in cardiac dysfunction","volume":"50","author":"Wu","year":"2018","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2023061411470614100_euad145-B42","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.08.862","article-title":"Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome","volume":"66","author":"Nademanee","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2023061411470614100_euad145-B43","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCEP.115.003220","article-title":"Brugada syndrome phenotype elimination by epicardial substrate ablation","volume":"8","author":"Brugada","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023061411470614100_euad145-B44","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"key":"2023061411470614100_euad145-B45","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.hrthm.2016.07.025","article-title":"Characterization of the epicardial substrate for catheter ablation of Brugada syndrome","volume":"13","author":"Zhang","year":"2016","journal-title":"Heart Rhythm"},{"key":"2023061411470614100_euad145-B46","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.hrthm.2017.01.006","article-title":"A novel method to enhance phenotype, epicardial functional substrates, and ventricular tachyarrhythmias in Brugada syndrome","volume":"14","author":"Chung","year":"2017","journal-title":"Heart Rhythm"},{"key":"2023061411470614100_euad145-B47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/eurheartj\/ehn520","article-title":"Transcriptional profiling of ion channel genes in Brugada syndrome and other right ventricular arrhythmogenic diseases","volume":"30","author":"Gaborit","year":"2009","journal-title":"Eur Heart J"},{"key":"2023061411470614100_euad145-B48","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1093\/eurheartj\/ehaa383","article-title":"An autoantibody profile detects Brugada syndrome and identifies abnormally expressed myocardial proteins","volume":"41","author":"Chatterjee","year":"2020","journal-title":"Eur Heart J"},{"key":"2023061411470614100_euad145-B49","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.jacc.2018.09.037","article-title":"Electroanatomic and pathologic right ventricular outflow tract abnormalities in patients with Brugada syndrome","volume":"72","author":"Pieroni","year":"2018","journal-title":"J Am Coll Cardiol"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/6\/euad145\/50595379\/euad145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/6\/euad145\/50595379\/euad145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T11:54:20Z","timestamp":1686743660000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euad145\/7197116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euad145","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2023,6]]},"article-number":"euad145"}}